Scott Kurtzman MD
Breast, Surgical Oncology (Other than Breast)
Professor of Surgery, Frank H Netter SOM and University of Connecticut
Join to View Full Profile
1625 Straits TpkeSuite 200Middlebury, CT 06762
Phone+1 203-568-2929
Fax+1 203-568-2921
Dr. Kurtzman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1988 - 1990
Rutgers Health/New Jersey Medical SchoolResidency, Surgery, 1985 - 1988
Clinical Center at the National Institutes of HealthResidency, Surgery, 1983 - 1985
University of MarylandResidency, Surgery, 1981 - 1983
Albany Medical CollegeClass of 1981
Certifications & Licensure
NY State Medical License 1988 - Present
CT State Medical License 1990 - 2025
NJ State Medical License 1985 - 1991
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2010-2014
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Computed Tomography Laser Mammography Breast Imaging Device Start of enrollment: 2015 Oct 01
Publications & Presentations
PubMed
- Did the COVID-19 consortium recommendations impact the treatment of breast cancer during the COVID-19 pandemic?Marie L Fefferman, Kelley Chan, Joseph Cotler, Danielle M Thompson, Richard J Bleicher
Breast Cancer Research and Treatment. 2025-05-01 - 2 citationsSmall Bowel Follow-Through: Treatment for Small Bowel Obstruction or Delaying the Inevitable?Mohammad Ali, Daniel R Slack, Emery Edmondson, Richard Feinn, Scott H Kurtzman
Cureus. 2023-12-01 - 13 citationsEvaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.Rachel Hae-Soo Joung, Timothy W Mullett, Scott H Kurtzman, Sarah Shafir, James B Harris
JAMA Network Open. 2022-11-01
Press Mentions
New Breast Cancer Standards Emphasize Individualized Patient CareApril 19th, 2023- National Quality Improvement Initiative Led by the American College of Surgeons Successfully Helped Address Pandemic-Related Cancer Screening DeficitsNovember 16th, 2022
- After Mastectomy Some Women Don’t Want to Replace Their BreastsJune 11th, 2022
- Join now to see all
Grant Support
- Clinical Trial: NSABP P-2: STARNational Center For Research Resources2008
- NSABP Treatment B21National Center For Research Resources2007
- Nsabp- B33National Center For Research Resources2006–2007
- NSABP P-2: STARNational Center For Research Resources2006–2007
- NSABP B-38National Center For Research Resources2006–2007
- NSABP B-28National Center For Research Resources2006–2007
- NSABP Co-7National Center For Research Resources2005–2007
- NSABP B-35National Center For Research Resources2005–2007
- NSABP B-31National Center For Research Resources2005–2007
- NSABP B-27National Center For Research Resources2005–2007
- Nsabp-B34National Center For Research Resources2004–2007
- NSABP P-1 TrialNational Center For Research Resources2006
- NSABP B23 AC VS CMFNational Center For Research Resources2005
- NSABP Protocol P-2: STARNational Center For Research Resources2004–2005
- Acsog-Z0010National Center For Research Resources2004–2005
- Trial To Determine The Worth Of Tamoxifen For Preventing Breast CancerNational Center For Research Resources1996–2005
- Worth Of Tamoxifen For Preventing Breast CancerNational Center For Research Resources2004
- HedaNational Center For Research Resources2004
- NSABP Treatment TrialsNational Center For Research Resources1997–2002
- NSABP P2--Tamoxifen &Raloxifene For Prevention Of Breast CancerNational Center For Research Resources2000
- NSABP B28--Taxol/Adriamycin/Cyclophosphamide In Breast CancerNational Center For Research Resources2000
- NSABP B27.1--Tumor Biomarkers In Breast CancerNational Center For Research Resources2000
- NSABP B23--Adriamycin/Cyclophosamide/Methotrexate/Fluorouracil In Breast CancerNational Center For Research Resources2000
- NSABP B23--Ac Versus CMF In Node Negative Breast CancerNational Center For Research Resources2000
- NSABP B1-65--Menstrual Cycle &Surgical Treatment Of Breast CancerNational Center For Research Resources2000
- NSABP B-27--Preoperative Doxorubicin/Cyclophosphamide/Docetaxel In Breast CancerNational Center For Research Resources2000
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
